U.S. Health Secretary Robert F. Kennedy Jr. has named eight new members to the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), following the abrupt dismissal of all 17 prior members. The newly appointed panel includes several figures known for expressing skepticism about vaccines, particularly mRNA technology.
Among the new appointees is Robert Malone, a vocal critic of mRNA COVID-19 vaccines and an ally of Kennedy’s "Make America Healthy Again" movement. Other members include Joseph Hibbeln, Martin Kulldorff, Retsef Levi, Cody Meissner, James Pagano, Vicky Pebsworth, and Michael Ross—some of whom have ties to prior CDC or FDA vaccine panels, while others have promoted views critical of current vaccination practices.
Kennedy, who has long challenged vaccine safety despite scientific consensus, claimed the former panel had conflicts of interest, although he did not provide specific evidence. He emphasized the reshuffle was meant to “restore public trust in vaccine science.”
The new ACIP members will participate in the committee’s June 25–27 meeting, where decisions are expected on vaccine recommendations for flu shots and the 2025–26 COVID-19 boosters. The meeting agenda has yet to be released.
The move sparked market reactions: Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) shares dipped slightly, while Novavax (NASDAQ:NVAX), which produces a non-mRNA COVID-19 vaccine, saw a marginal rise.
Concerns remain about the vetting process for the new members. Some, like Pebsworth and Meissner, have served on FDA advisory committees, while others, such as Levi and Kulldorff, have made controversial statements questioning mRNA vaccine safety.
Despite FDA confirmation that mRNA vaccines are safe and effective, Kennedy’s overhaul has intensified the national debate on vaccine policy and public health strategy.


Lukashenko Says Maduro Welcome in Belarus Amid Rising U.S.-Venezuela Tensions
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
U.S. and Mexico Reach New Agreement to Tackle Tijuana River Sewage Crisis
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
International Outcry Grows Over Re-Arrest of Nobel Laureate Narges Mohammadi in Iran
Zelenskiy Signals Willingness to Drop NATO Bid as Ukraine, U.S. Hold Crucial Peace Talks in Berlin
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Global Leaders Condemn Deadly Antisemitic Shooting at Sydney’s Bondi Beach During Hanukkah
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
European Leaders Launch International Claims Commission to Compensate Ukraine for War Damage
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Trump Weighs Reclassifying Marijuana as Schedule III, Potentially Transforming U.S. Cannabis Industry 



